Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform

Biosenic SA

30/01/2024 06:08

Jan 30 (Reuters) - BioSenic SA  BIOS.BR :
    * BIOSENIC PATENT GRANTED IN CANADA FOR BROADER PROTECTION
OF ITS
ATO THERAPEUTIC PLATFORM
    * COMPOSITION-OF-MATTER PATENT COVERS THERAPEUTIC USE OF
ARSENIC
SALTS AND METAL IONS THROUGH VARIOUS ROUTES OF ADMINISTRATION
    * ENRICHED IP PORTFOLIO PROTECTS ARSENIC TRIOXIDE (ATO) USE
COMBINED WITH COPPER IONS DELIVERY, WHICH HAS DEMONSTRATED
INCREASED THERAPEUTIC POTENTIAL FOR INDICATIONS RANGING FROM
IMMUNE TO CANCER AND INFECTIOUS DISEASES
    * BIOSENIC WILL BE ABLE TO CONTINUE CLINICAL DEVELOPMENT
WITH
PROPRIETARY ORIGINAL FORMULATIONS CONTAINING ARSENIC AND NEW
ACTIVE INGREDIENTS SUCH AS METAL IONS, INCREASING POTENCY OF ITS
PRODUCTS, AND MINIMIZING SECONDARY SIDE EFFECTS

Source text for Eikon:  ID:nGNE5lPhNx 
Further company coverage:  BIOS.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))